Retatrutide (GLP-3R 20MG)

Retatrutide (GLP-3R 20MG) is a novel triple agonist of the glucose-dependent insulinotropic polypeptide, glucagon-like peptide 1 and glucagon receptors.

Retatrutide (RETA; LY3437943) is a single protein conjugated to a fatty diacid moiety that activates human GIP, GLP-1 and GCG receptors. On the basis of cell culture studies, retatrutide is less potent than endogenous ligands of the human GCG and GLP-1 receptors (0.3 and 0.4 times as active, respectively) and is more potent at the human GIP receptor (by a factor of 8.9)¹¹. The pharmacokinetics of retatrutide are dose proportional; it has a half-life of approximately 6 days.

Molecular Formula : C₂₂₁H₃₄₂N₄₆O₆₈.xC₂HF₃O₂

Usage : This product is designated solely for use as a research chemical. It is intended exclusively for in vitro studies and laboratory-based experimentation. All content provided on this website is for educational use only. Introducing this substance into the body of humans or animals is strictly prohibited by law. Only trained and licensed professionals should handle this material. It is not classified as a drug, food, or cosmetic and must not be marketed, labeled, or used as such.

Availability : All items are delivered in a lyophilized or powdered state and must be reconstituted into a liquid form prior to research or testing. While we do not offer any dosing guidelines, all products are considered to meet pharmaceutical-grade standards.

Storage Instructions:
Keep the product in a cool, dry location away from direct light. If reconstituted, it should be stored in a refrigerator. For extended storage, freezing at -20°C is advised to preserve its stability.